NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Hoffmann,

While I agree that some damage would have been done by the absents of Dr. Liau, I believe that if the company issued a PR indicating that Dr. Liau had Covid and wouldn't be able to make the presentation before AdamF broke the news, the attack would have been far less severe. If Clinical Trials had been updated to eliminate the PFS goal, and that been established well before the conference, AdamF and many others wouldn't have had a leg to stand on. While I have supported the company in doing what they planned, I question why they put off making such announcements, especially when it had already been made the case in the European Clinical Trials.

I certainly don't know of any reason that Clinical Trials couldn't have been revised earlier, but anything is possible. I can understand the regulators wanting certain things and likewise the Journal, I just don't know why either would have insisted on not updating clinical trials until when they did it.

Gary